Successful synthesis of a glial‐specific blood–brain barrier shuttle peptide following a fragment condensation approach on a solid‐phase resin

Successful manual synthesis of the TD2.2 peptide acting as a blood–brain barrier shuttle was achieved. TD2.2 was successfully synthesised by sequential condensation of four protected peptide fragments on solid‐phase settings, after several unsuccessful attempts using the stepwise approach. These fragments were chosen to minimise the number of demanding amino acids (in terms of coupling, Fmoc removal) in each fragment that are expected to hamper the overall synthetic process. Thus, the hydrophobic amino acids as well as Arg(Pbf) were strategically spread over multiple fragments rather than having them congested in one fragment. This study shows how a peptide that shows big challenges in the synthesis using the common stepwise elongation methodology can be synthesised with an acceptable purity. It also emphasises that choosing the right fragment with certain amino acid constituents is key for a successful synthesis. It is worth highlighting that lower amounts of reagents were required to synthesise the final peptide with an identical purity to that obtained by the automatic synthesiser.

[1]  F. Albericio,et al.  2021 FDA TIDES (Peptides and Oligonucleotides) Harvest , 2022, Pharmaceuticals.

[2]  Haifeng Hu,et al.  Efficient synthesis of Aib8‐Arg34‐GLP‐1 (7–37) by liquid‐phase fragment condensation , 2022, Journal of peptide science : an official publication of the European Peptide Society.

[3]  M. Zahid,et al.  Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics , 2021, Pharmaceutics.

[4]  Sanyog Jain,et al.  Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics. , 2020, Biomaterials science.

[5]  V. Torchilin,et al.  Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Ü. Langel,et al.  Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics , 2020, Expert opinion on biological therapy.

[7]  A. Falanga,et al.  The world of cell penetrating: the future of medical applications. , 2020, Future medicinal chemistry.

[8]  N. Nikkam,et al.  Transcellular brain drug delivery: A review on recent advancements. , 2020, International journal of pharmaceutics.

[9]  Robert J. Lee,et al.  Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application , 2020, Frontiers in Pharmacology.

[10]  F. Albericio,et al.  2019 FDA TIDES (Peptides and Oligonucleotides) Harvest , 2020, Pharmaceuticals.

[11]  F. Albericio,et al.  Greening Fmoc/tBu solid-phase peptide synthesis , 2020 .

[12]  Y. Anraku,et al.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. , 2019, Biomaterials.

[13]  F. Albericio,et al.  γ-Valerolactone (GVL): An eco-friendly anchoring solvent for solid-phase peptide synthesis , 2019, Tetrahedron Letters.

[14]  T. Svensson,et al.  2D green SPPS: green solvents for on-resin removal of acid sensitive protecting groups and lactamization , 2019, Green Chemistry.

[15]  Thomas L. Williams,et al.  Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines , 2019, Scientific Reports.

[16]  Ashish Kumar,et al.  Troubleshooting When Using γ-Valerolactone (GVL) in Green Solid-Phase Peptide Synthesis , 2019, Organic Process Research & Development.

[17]  F. Albericio,et al.  Pseudo-Wang Handle for the Preparation of Fully Protected Peptides. Synthesis of Liraglutide by Fragment Condensation. , 2019, Organic letters.

[18]  H. Derakhshankhah,et al.  Cell penetrating peptides: A concise review with emphasis on biomedical applications. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Yahya E. Jad,et al.  Greening the Solid-Phase Peptide Synthesis Process. 2-MeTHF for the Incorporation of the First Amino Acid and Precipitation of Peptides after Global Deprotection , 2018, Organic Process Research & Development.

[20]  G. Morelli,et al.  Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery , 2018, Scientific Reports.

[21]  E. Giralt,et al.  Jumping Hurdles: Peptides Able To Overcome Biological Barriers. , 2017, Accounts of chemical research.

[22]  D. Jaradat Thirteen decades of peptide synthesis: key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation , 2017, Amino Acids.

[23]  Ernest Giralt,et al.  Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery. , 2016, Chemical Society reviews.

[24]  Jiaxi Wang,et al.  Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Jing He,et al.  Mechanism Matters: A Taxonomy of Cell Penetrating Peptides. , 2015, Trends in biochemical sciences.

[26]  G. Guillemin,et al.  Design and Screening of a Glial Cell-Specific, Cell Penetrating Peptide for Therapeutic Applications in Multiple Sclerosis , 2012, PloS one.

[27]  W. Pardridge The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[28]  Ulo Langel,et al.  Cell-penetrating peptides: mechanism and kinetics of cargo delivery. , 2005, Advanced drug delivery reviews.

[29]  D. Gatos,et al.  Comparison of the stepwise and convergent approaches in the solid-phase synthesis of rat Tyr0-atriopeptin II , 2004, Letters in Peptide Science.

[30]  Dimitrios Gatos,et al.  Application of 2-chlorotrityl chloride in convergent peptide synthesis , 1995 .

[31]  Herbert Benz,et al.  The Role of Solid-Phase Fragment Condensation (SPFC) in Peptide Synthesis , 2010 .

[32]  Kit S. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[33]  R. B. Merrifield Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[34]  Microwave technology for solid phase peptide synthesis It ’ s not just for difficult peptides , 2022 .